Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Australian Clinical Labs Ltd has announced that Comet Asia Holdings and KKR entities have ceased to be substantial holders as of November 15, 2024. This change in ownership could impact the company’s stock dynamics and investor perceptions. Market participants may want to watch how this development influences the company’s future market movements.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.